Direct-To-Consumer (DTC) Genetic Testing Market: Analyzing Market Size, Growth Trends, Demand Drivers, and Future Outlook

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $3.32 billion In 2028 At A CAGR Of 16.1% :

The direct-to-consumer (DTC) genetic testing market size has grown rapidly in recent years. It will grow from $1.57 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to curiosity about ancestry and heritage, health and wellness trends, marketing and consumer education, privacy and control over genetic data, affordability and accessibility.

The direct-to-consumer (DTC) genetic testing market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to expanding test offerings, integration with personalized medicine, collaborations with health and wellness industries, advancements in genetic research, government support and regulations. Major trends in the forecast period include expanding test offerings and panels, educational initiatives for consumers, regulatory compliance and oversight, genomic data research and contributions, price reduction and accessibility.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp

Direct-To-Consumer (DTC) Genetic Testing Market Major Segments
The direct-to-consumer (DTC) genetic testing market covered in this report is segmented -

1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types
2) By Sample: Saliva, Urine, Blood
3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis
4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode
5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User

Key Driver - Rising Disease Prevalence Spurs Growth In Direct-To-Consumer Genetic Testing Market

The rising prevalence of diseases and disorders with genetic transmission capabilities is expected to propel the growth of the direct-to-consumer (DTC) genetic testing market going forward. Genetic disorder refers to an illness caused by changes (mutation) in a person's DNA and it includes single-gene, multifactorial and chromosomal disorders. Direct-to-consumer genetic testing promotes awareness of various genetic disorders that helps in making predictions about health and provides personalized information about an individual's health, disease risk, and other traits, thus, helps in taking effective health and lifestyle decisions to reduce the disease risk. For instance, according to MedlinePlus, a US-based online information service provided by the United States National Library of Medicine, in 2021, syndrome A is identified in about 1 in 200,000 Americans each year and currently around 100,000 kids suffer from syndrome B, whereas, it is estimated that nearly 12,000 people died globally from syndrome C in 2020 and approximately 1% of people in the United States develop disorder D during their lifetimes. Furthermore, in February 2022, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations responsible for international public health, birth abnormalities cause 240,000 new-borns to pass away in the first 28 days of life each year and an additional 170,000 children between the ages of 1 month and 5 years die as a result of birth abnormalities which includes heart defects, neural tube defects, and Down syndrome (a genetic disorder). Therefore, the rising prevalence of diseases and disorders with genetic transmission capabilities is driving the growth of the direct-to-consumer (DTC) genetic testing market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=8957&type=smp

Prominent Trend - Major Players Bolster Dtc Genetic Testing Market Through Strategic Genetic Research Investments

Major companies operating in the direct-to-consumer (DTC) genetic testing market are focusing on investing in genetic research to sustain their position in the market. Investments provide the necessary financial backing for genetic testing companies to conduct research, enhance technologies, expand market reach, ensure compliance, and drive innovation. For instance, in November 2022, Redcliffe Labs, an India-based diagnostic centers & diagnosis labs, has announced its plan to invest an additional $10 million (around Rs 81 crore) towards the expansion of its genetic and specialized testing portfolio. This investment is intended to further develop the company's genetic testing capabilities, including areas such as prenatal, oncology, neurology, nephrology, and pharmacogenomics. The company has already invested $6 million in genetics and specialized testing coverage and is focused on next-generation technologies in the diagnostics space.

Direct-To-Consumer (DTC) Genetic Testing Market Players
Major companies operating in the direct-to-consumer (DTC) genetic testing market report are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Konica Minolta, Inc., Genesis HealthCare, Inc., Ancestry.com LLC, Myriad Genetics, Inc., Fulgent Genetics, Inc., Sonora Quest Laboratories LLC, Prenetics Limited, 23andMe Holding Co., Color Health Inc., Living DNA Limited, MyHeritage Ltd., Victorian Clinical Genetics Services, Dante Labs S.r.l., Helix OpCo LLC, Gene by Gene, Ltd., Gene by Gene, Ltd., EasyDNA Ltd., Pathway Genomics Corporation, Full Genomes Corporation, Identigene LLC, Mapmygenome Labs Pvt. Ltd., Positive Bioscience Inc., Xcode Life Sciences Private Limited, 24Genetics S.L., Direct Laboratory Services, LLC, Karmagenes SA, Request A Test Ltd., Any Lab Test Now, LLC

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2023. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Direct-To-Consumer (DTC) Genetic Testing Market Report Structure
3. Direct-To-Consumer (DTC) Genetic Testing Market Trends And Strategies
4. Direct-To-Consumer (DTC) Genetic Testing Market - Macro Economic Scenario
5. Direct-To-Consumer (DTC) Genetic Testing Market Size And Growth
…..
27. Direct-To-Consumer (DTC) Genetic Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.